[home]
[thesaurus]
Click Here to return To Results
Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis
NEJM 366:1000-1009, Comi,G.,et al, 2012
See this aricle in Pubmed
Article Abstract
In this phase 3 study, oral laquinimod administered once daily slowed the progression of disability and reduced the rate of relapse in patients with relapsing-remitting multiple sclerosis.
Related Tags
(click to filter results - removes previous filter)
adverse drug reaction
complications
efficacy
laquinimod
liver function enzymes
multiple sclerosis
multiple sclerosis,prophylaxsis
multiple sclerosis,relapsing
multiple sclerosis,treatment of
safety
treatment of neurologic disorder
Click Here to return To Results